7000 ORAL Final Overall Survival (OS) Analysis of COU-AA-301, a Phase 3 Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Pretreated With Docetaxel
- Resource Type
- Abstract
- Source
European Journal of Cancer . Sep2011 Supplement 1, Vol. 47, pS483-S484. 0p.- Subject
- Language
- ISSN
- 0959-8049